Migdal Insurance & Financial Holdings Ltd. Avrobio, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$7.84 - $12.6 $397,056 - $638,127
-50,645 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$10.54 - $19.3 $331,261 - $606,579
31,429 Added 163.56%
50,645 $643,000
Q4 2020

Feb 08, 2021
BUY
$12.79 - $17.1 $245,772 - $328,593
19,216 New
19,216 $268,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email